当前位置:首页 - 行情中心 - 安科生物(300009) - 财务分析

安科生物

(300009)

  

流通市值:128.65亿  总市值:176.12亿
流通股本:12.22亿   总股本:16.73亿

安科生物(300009)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润3.75亿元,每股收益0.22元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益414372.13万元,未分配利润156945.82万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产492296.29万元,负债77924.16万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入1,292,187,881.95628,754,570.482,536,042,781.681,921,280,101.12
营业总成本885,306,876.29394,534,887.631,780,935,163.991,268,341,322.03
其他经营收益
营业利润432,330,760.51247,966,620.6806,396,813.46699,364,367
利润总额432,081,021.92247,862,906.26803,016,702.92698,275,336.46
净利润374,553,615.38213,314,968.37715,837,906.16599,915,131.57
每股收益
其他综合收益-71,008,287.24-44,881,085.5--
综合收益总额303,545,328.14168,433,882.87715,837,906.16599,915,131.57
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计2,080,675,526.92,091,782,205.872,275,095,785.012,240,715,100.01
非流动资产:
非流动资产合计2,842,287,396.643,012,443,453.752,860,254,070.712,750,263,372.7
资产总计4,922,962,923.545,104,225,659.625,135,349,855.724,990,978,472.71
流动负债:
流动负债合计619,410,400.7681,080,762.88667,585,431.63699,754,762.31
非流动负债:
非流动负债合计159,831,213.97162,385,516.67167,826,723.08158,813,455.35
负债合计779,241,614.67843,466,279.55835,412,154.71858,568,217.66
所有者权益(或股东权益):
归属于母公司股东权益合计3,970,430,014.834,085,098,104.474,124,312,564.423,937,686,124.91
股东权益合计4,143,721,308.874,260,759,380.074,299,937,701.014,132,410,255.05
负债和股东权益合计4,922,962,923.545,104,225,659.625,135,349,855.724,990,978,472.71
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计1,278,724,469.39593,182,584.392,505,216,350.951,875,989,512.27
经营活动现金流出小计962,299,635.08397,953,607.491,819,844,403.861,455,085,023.09
经营活动产生的现金流量净额316,424,834.31195,228,976.9685,371,947.09420,904,489.18
投资活动产生的现金流量:
投资活动现金流入小计982,110,968.71984,226,816.561,262,223,715.451,160,526,336.56
投资活动现金流出小计801,658,281.841,008,274,689.411,432,471,328.521,044,603,561.67
投资活动产生的现金流量净额180,452,686.87-24,047,872.85-170,247,613.07115,922,774.89
筹资活动产生的现金流量:
筹资活动现金流入小计18,313,750-5,000,0005,000,000
筹资活动现金流出小计483,420,902.91206,540,716.57480,379,750.73449,876,950.15
筹资活动产生的现金流量净额-465,107,152.91-206,540,716.57-475,379,750.73-444,876,950.15
汇率变动对现金及现金等价物的影响-2,908,775.77-2,470,049.3376,401.9447,093.95
现金及现金等价物净增加额28,861,592.5-37,829,661.8539,820,985.2391,997,407.87
期末现金及现金等价物余额327,466,527.47260,775,273.12298,604,934.97350,781,357.61
补充资料:
现金及现金等价物的净增加额28,861,592.5-39,820,985.23-
最新报告期:2025-08-27
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
华安证券李雨涵,谭国超0.450.520.602025-08-27
华鑫证券吴景欢,胡博新0.480.560.652025-08-26
TOP↑